One of the Listed companies, Central Pharmaceuticals Ltd. has recommended NO Dividend for the year ended June 30, 2023.
In terms of financial performance, the company has reported Earnings Per Share (EPS) loss of Tk. 0.37 for the year ending June 30, 2023. NAV per share of Tk. 5.59 for the year ended June 30, 2023.
The Annual General Meeting (AGM) of the company will be held on December 28, through the digital platform. The record date for this has been fixed at November 23.
Share this
